BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 29158834)

  • 1. Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy.
    Li H; Li Y; Wang X; Hou Y; Hong X; Gong T; Zhang Z; Sun X
    Theranostics; 2017; 7(18):4383-4398. PubMed ID: 29158834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses.
    Zeng Q; Jiang H; Wang T; Zhang Z; Gong T; Sun X
    J Control Release; 2015 Feb; 200():1-12. PubMed ID: 25540903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
    Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L
    J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-loaded polymeric hybrid micelles elicit strong mucosal and systemic immune responses after intranasal administration.
    Li Y; Li M; Gong T; Zhang Z; Sun X
    J Control Release; 2017 Sep; 262():151-158. PubMed ID: 28756271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant.
    Jérôme V; Graser A; Müller R; Kontermann RE; Konur A
    J Immunother; 2006; 29(3):294-305. PubMed ID: 16699372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailoring polymeric hybrid micelles with lymph node targeting ability to improve the potency of cancer vaccines.
    Zeng Q; Li H; Jiang H; Yu J; Wang Y; Ke H; Gong T; Zhang Z; Sun X
    Biomaterials; 2017 Apr; 122():105-113. PubMed ID: 28110170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
    Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
    Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs.
    Kapadia CH; Tian S; Perry JL; Luft JC; DeSimone JM
    Mol Pharm; 2016 Oct; 13(10):3381-3394. PubMed ID: 27551741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cationic MPEG-PCL-g-PEI micelles for co-delivery of Msurvivin T34A gene and doxorubicin.
    Shi S; Shi K; Tan L; Qu Y; Shen G; Chu B; Zhang S; Su X; Li X; Wei Y; Qian Z
    Biomaterials; 2014 May; 35(15):4536-47. PubMed ID: 24582554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy.
    Su Q; Wang C; Song H; Zhang C; Liu J; Huang P; Zhang Y; Zhang J; Wang W
    J Mater Chem B; 2021 May; 9(18):3892-3899. PubMed ID: 33928989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2K(b) and H-2D(b)-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma.
    Zhuang X; Wu T; Zhao Y; Hu X; Bao Y; Guo Y; Song Q; Li G; Tan S; Zhang Z
    J Control Release; 2016 Apr; 228():26-37. PubMed ID: 26921522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
    Mochizuki S; Morishita H; Kobiyama K; Aoshi T; Ishii KJ; Sakurai K
    J Control Release; 2015 Dec; 220(Pt A):495-502. PubMed ID: 26562685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma.
    Mu LM; Liu L; Liu R; Du YF; Luo Q; Xu JR; Xie Y; Lu WL
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
    Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
    J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
    Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
    ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
    Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
    Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending antigen release from particulate vaccines results in enhanced antitumor immune response.
    Kapadia CH; Tian S; Perry JL; Sailer D; Christopher Luft J; DeSimone JM
    J Control Release; 2018 Jan; 269():393-404. PubMed ID: 29146244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma.
    Zhu M; Ding X; Zhao R; Liu X; Shen H; Cai C; Ferrari M; Wang HY; Wang RF
    J Control Release; 2018 Feb; 272():72-82. PubMed ID: 29325699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.